Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction
- 3 October 2011
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (42), 17432-17437
- https://doi.org/10.1073/pnas.1107303108
Abstract
The suppression of oncogenic levels of MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known as oncogene addiction. However, after prolonged inactivation of MYC in a conditional transgenic mouse model of Eμ-tTA/tetO-MYC T-cell acute lymphoblastic leukemia, some of the tumors recur, recapitulating what is frequently observed in human tumors in response to targeted therapies. Here we report that these recurring lymphomas express either transgenic or endogenous Myc, albeit in many cases at levels below those in the original tumor, suggesting that tumors continue to be addicted to MYC. Many of the recurring lymphomas (76%) harbored mutations in the tetracycline transactivator, resulting in expression of the MYC transgene even in the presence of doxycycline. Some of the remaining recurring tumors expressed high levels of endogenous Myc, which was associated with a genomic rearrangement of the endogenous Myc locus or activation of Notch1. By gene expression profiling, we confirmed that the primary and recurring tumors have highly similar transcriptomes. Importantly, shRNA-mediated suppression of the high levels of MYC in recurring tumors elicited both suppression of proliferation and increased apoptosis, confirming that these tumors remain oncogene addicted. These results suggest that tumors induced by MYC remain addicted to overexpression of this oncogene.Keywords
This publication has 49 references indexed in Scilit:
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004
- Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experimentsFEBS Letters, 2004
- The many faces of c-MYCArchives of Biochemistry and Biophysics, 2003
- Reversible Activation of c-Myc in Skin: Induction of a Complex Neoplastic Phenotype by a Single Oncogenic LesionMolecular Cell, 1999
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Ras Enhances Myc Protein StabilityMolecular Cell, 1999
- c-Myc Target Genes Involved in Cell Growth, Apoptosis, and MetabolismMolecular and Cellular Biology, 1999
- Identification of c- MYC as a Target of the APC PathwayScience, 1998
- The ornithine decarboxylase gene is a transcriptional target of c-Myc.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proceedings of the National Academy of Sciences of the United States of America, 1992